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ABSTRACT: A contemporary synthetic route, starting from the bioactive compound via the 
corresponding glycidyl ester and β-substituted β-lactone to (homo)- and (co)oligoesters with a 
bioactive moiety covalently linked as pendent groups along an oligomer backbone, was reported. 
The bioactive compounds were selected from antioxidants used in cosmetics. Two models of 
bioactive (homo)- and (co)oligoesters were synthesized via anionic ring-opening 
(co)oligomerization of p-methoxybenzoyloxymethylpropiolactone (p-AA-CH2-PL) initiated by 
p-anisic acid sodium salt. An analytical protocol was developed for a detailed structural 
characterization at the molecular level of these bioactive (co)oligoesters.  The molecular level 
structure of the obtained bioactive (homo)- and (co)oligoesters was established by electrospray 
ionization tandem mass spectrometry (ESI-MS/MS) supported by 1H NMR analysis. 
Additionally, the results presented here are important for the analysis of designed biodegradable 
polymeric controlled-release systems of bioactive compounds with potential applications in 
cosmetology.   
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1. Introduction  
Increased interest in bioactive compounds is related to the potential possibilities of using them 
as agents added to food, cosmetics or pharmaceuticals. The term ‘bioactive substances’ 
encompasses all components comprising therapeutic and nutritional substances that are normally 
found in plants in small quantities 1. A well-known group of bioactive agents are phenolic 
compounds which include, e.g. flavonoids, phenolic acids or tannins. Phenolic acids are aromatic 
secondary plant metabolites which are widely spread throughout the plant kingdom. This group 
include hydroxyl derivatives of cinnamic acid and benzoic acid. Phenolic acids can be easily 
absorbed in the human system and offer a host of anti-aging benefits. They also reveal very good 
preservative properties, including antibacterial and antifungal effects 2. 
 p-Anisic  acid (benzoic acid derivative) possesses antioxidant, anti-tumor and anti-
inflammatory properties; it has also been found that it has biochemical properties, thus making it 
suitable as a cosmetic ingredient 3. p-Anisic acid has recently become increasingly significant as 
a multi-functional raw material in both the cosmetics and food industries 4. Today, several 
antimicrobial fragrance ingredients are commercially available, such as, p-anisic acid (p-
methoxybenzoic acid) and levulinic acid (4-oxopentanoic acid), which were found to be the main 
compounds in Pimpinella anisum and other herbs and in Dioscorea villosa as a by-product in the 
production of diosgenin from wild yam, respectively 5. 
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The development of macromolecules with a defined structure and properties, aimed 
specifically for biomedical applications, has resulted in diverse biodegradable polymers with 
advanced architectures. Recently, the attachment of cosmetics to specific polymer carriers has 
spurred particular interest. PHAs, mostly poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-
co-3-hydroxyvalerate), have been used as carriers for drug delivery because of their 
biocompatibility, biodegradability and controllable retarding properties which can be modulated 
by variations in the processing and molecular weight of the polymer composition 6-7. The 
synthetic analogue of PHAs can be obtained via anionic ring-opening polymerization of β-
substituted β-lactones, e.g. atactic poly(3-hydroxybutyrate) is obtained via anionic ROP of β-
butyrolactone 8. 
β-Lactones are attractive intermediates in organic synthesis 9 and are useful as monomers in 
ROP 10-12. Among the synthetic methods for their preparation, carbonylation of epoxides seems 
to be the most effective approach. In recent years, highly active and selective catalysts for 
epoxide carbonylation have been discovered 13-15, which opened up access to a new source of 
biologically active β-lactone monomers and turned out to have very beneficial and far-reaching 
consequences in the synthesis of new bioactive polyesters, including polymeric delivery systems. 
Herein, we report the synthetic strategy for bioactive (co)oligoesters based on anionic homo- 
and co-polymerization of β-substituted β-lactones containing bioactive moieties selected from 
compounds used as preservatives and antioxidants in cosmetics. The ability of these lactones to 
undergo anionic ring-opening oligomerization in the presence of metal-free anionic initiators has 
been demonstrated.  
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These novel bioactive (co)oligoesters have a larger loading of biologically active substances 
(p-anisic acid, p-AA) per polymer macromolecule in comparison to the already reported 
conjugates of oligo(3-hydroxybutyrate) (OHB) with several selected antioxidants 16-18.  
Taking into consideration the prospective use of synthesized new control delivery systems in 
cosmetics and their contact with the skin, it was important to elucidate the structure and 
homogeneity of the obtained products.  
Previously, mass spectrometry was successfully applied for structural characterization at the 
molecular level of homopolyesters, copolyesters and their degradation products 19-29. In our 
recent works we reported the application of ESI-MS/MS techniques for characterization at the 
molecular level of OHB conjugates with bioactive compounds including antioxidants used in 
cosmetics. The molecular structure of bioconjugates, in which antioxidants (α-lipoic, p-coumaric, 
p-anisic and vanillic acids) are covalently bonded to OHB chains as the end group, has also been 
proven by tandem mass spectrometry 16-18. We have also demonstrated the utility of this 
technique for the analysis of individual molecules of homo- and co-polyesters obtained by 
anionic ring-opening copolymerization of selected β-substituted β-lactones 11-12. 
In the present study, electrospray mass spectrometry was applied in order to obtain more 
detailed structural information about bioactive (co)oligoesters containing bioactive moieties (p-
anisic acid) along the oligomer chains. The structure of individual macromolecules of the 
resulting (co)oligoesters (including the chemical structure of their end groups) was determined 
using ESI-MSn supported by 1H NMR spectroscopy. The chemical structure of the individual 
(co)oligoester chains was confirmed by ESI-MS/MS and by investigating the fragmentation 
product patterns of individual molecular ions.  
2. Experimental Part 
4 
 
2.1. Materials. (R,S)-β-Butyrolactone (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) 
was distilled over CaH2 and the fraction boiling at 56 °C (9 mmHg) was collected. 4-
Methoxybenzoyloxymethythylpropiolactone (p-AA-CH2-PL) was synthesized by carbonylation 
of the respective epoxide under ambient CO pressure 30. p-Anisic acid sodium salt (sodium p-
anisate, 4-methoxybenzoic acid sodium salt for synthesis, MERCK), dimethylsulfoxide (DMSO, 
99.8%, Aldrich) were used as received.  
2.2 Synthesis of 4-methoxybenzoyloxymethylpropiolactone 
2.2.1 General considerations 
NMR spectra were recorded using a Varian Mercury spectrometer (1H NMR, 500 MHz; 13C 
NMR, 125 MHz) and referenced against tetramethylsilane as an internal standard. The following 
abbreviations were used to indicate multiplicity: s, singlet; d, doublet; t, triplet; br, broad spin 
system; m, multiplet; coupling constants are reported in Hz. Analytical TLC was carried out on 
commercial plates coated with 0.25 mm Merck Kieselgel 60. Preparative flash silica 
chromatography was performed using Merck Kieselgel 60 (230-400 mesh). All manipulations of 
air- and/or water-sensitive compounds were carried out using standard Schlenk line techniques 
under an atmosphere of dry argon. All carbonylation reactions were set up and run in a well-
ventilated fume hood equipped with a carbon monoxide detector (see MSDS for proper handling 
of CO). Dimethoxyethane and methylene chloride were dried by distillation over CaH2 prior to 
use. 
2.2.3. Preparation of glycidyl 4-methoxybenzoate (p-anisate) 
A catalytic amount of DMF was added (ca. 0.2 mL) to a stirred suspension of 4-
methoxybenzoic acid (11.4 g, 0.075 mol) in 100 mL of anhydrous methylene chloride. Oxalyl 
chloride (7.7 mL, 0.09 mol) was then added dropwise and the suspension was stirred at RT until 
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it became clear (2-3 h). The solution was then concentrated in vacuo and acid chloride was used 
directly in the next step without any further purification. 
4-Methoxybenzoyl chloride was added dropwise to a stirred solution of glycidol (6mL, 0.09 
mol) and triethylamine (12.5 mL, 0.09 mol) in 100 mL of anhydrous methylene chloride at 0 °C. 
The reaction mixture was then allowed to reach RT, was stirred for 3 h and then quenched with 
saturated NH4Cl solution. The organic layer was washed with 1M HCl, water, brine, dried over 
anhydrous MgSO4 and concentrated in vacuo. The crude ester was crystallized (ethyl 
acetate/hexane) and isolated as white crystals (13.5 g, 80%). 
2.2.4. Procedure for carbonylation of glycidyl 4-methoxybenzoate (p-anisate) 
[N,N’-Bis(3,5-di-tert-butylsalicydene)-1,2-phenylenediaminochromium]chloride (0.9 mmol, 564 
mg), Co2(CO)8 (1,35 mmol, 462 mg) and glycidyl 4-methoxybenzoate (30 mmol, 6.78 g) were 
placed in an oven-dried Schlenk tube equipped with a magnetic stir bar under an argon 
atmosphere. The reaction vessel was then equipped with a latex balloon containing carbon 
monoxide and was subjected to three vacuum/CO cycles. Anhydrous dimethoxyethane (30 mL) 
was added via syringe and the reaction was stirred overnight. Then CO gas was carefully vented 
off. The reaction mixture was evaporated under reduced pressure and the residue was purified by 
flash column chromatography (hexane, ethyl acetate) to give  
4-methoxybenzoyloxymethylpropiolactone (4.95 g, 65%). 
O
O
O
O
MeO  
1H NMR (CDCl3, 500 MHz) δ 7.99 (d, 2H, J = 9 Hz), 6.93 (d, 2H, J = 8.8 Hz), 4.86 (m, 1H), 
4.69 (dd, 1H, 1J = 13 Hz, 2J = 3 Hz), 4.53 (dd, 1H, 1J = 13 Hz, 2J = 5 Hz), 3.87 (s, 3H), 3.62 (dd, 
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1H, 1J = 16 Hz, 2J = 6 Hz), 3.43 (dd, 1H, 1J = 16 Hz, 2J = 4 Hz), 13C NMR (125 MHz) δ 40.2, 
55.4, 63.4, 67.9, 113.8, 121.3, 131.8, 163.8, 165.6, 166.7; IR (neat, KBr) νCO = 1830 cm-1 
2.3. Oligomerization of 4-methoxybenzoyloxymethylpropiolactone in the presence of p-anisic 
acid sodium salt. 
The bioactive (homo)oligoester containing the p-anisic acid moiety e.g. oligo(3-hydroxy-3-(4-
methoxybenzoyloxymethyl)propionate) (p-AA-CH2-HP)n was prepared via anionic ring-opening 
polymerization of β-substituted β-lactone containing the p-anisic acid moiety, e.g. 4-
methoxybenzoyloxymethylpropiolactone (p-AA-CH2-PL). The reaction was conducted in 
dimethylosulfoxide (DMSO) at room temperature in a glass reactor that was flamed and dry 
argon-purged prior to use. The monomer p-AA-CH2-PL (0.20 g, 0.85 mmol) was added to 
reactors that contained the solvent DMSO (4 mL) and the required amount of initiator: p-anisic 
acid sodium salt (sodium p-anisate, (CH3OPhC(O)O-Na+), 0,02 g, 0,13 mmol). The average 
molar mass of the conjugates was controlled by the monomer-initiator ratio. The progress of 
polymerization was monitored by Fourier transform infrared spectroscopy (FT-IR) based on the 
intensity of the signals arising from the carbonyl groups of the monomer and oligomer at 1837 
and 1743 cm-1, respectively. After the completion of oligomerization, the resulting oligomers 
were precipitated from cold hexane and dried under vacuum. Chloroform solutions of oligomers 
were acidified with dilute HCl(aq) and the mixtures were stirred vigorously for 10 min. After 
phase separation, the organic layer was removed and acidified again (as described above). Then 
the oligomer solution was washed 10 times with 5 mL of distilled water. Next, the solvent was 
evaporated and the oligomers were dried under vacuum at room temperature for 48 h and 
analyzed.  
7 
 
2.4. (Co)oligomerization of 4-methoxybenzoyloxymethylpropiolactone in the presence of p-anisic 
acid sodium salt. 
The bioactive random (co)oligoester containing the p-anisic acid moiety e.g. oligo[(3-hydroxy-
3-(4-methoxybenzoyloxymethyl)propionate)-co-(3-hydroxybutyrate)] was prepared via anionic 
ring-opening copolymerization of β-substituted β-lactone containing the p-anisic moiety (p-AA-
CH2-PL) with β-butyrolactone (β-BL). The reaction was performed under an argon atmosphere 
at room temperature. Monomers p-AA-CH2-PL (0.20 g, 0.85 mmol) and β-BL (0.073 mL, 0.85 
mmol) were added to reactors containing the solvent: DMSO 5 mL and the required amount of 
initiator: sodium p-anisate, (CH3OPhC(O)O-Na+), (0.031 g, 0.18 mmol). Progress of the 
copolymerization was monitored by FT-IR spectroscopy based on the intensity of the carbonyl-
group signals of the monomers at 1837 cm-1 (p-AA-CH2-PL) and 1830 cm-1 (β-BL) and that of 
the oligomers at 1740 cm-1. The resulting (co)oligoesters were purified as described above. 
2.5. Measurements:  
2.5.1. Size-Exclusion Chromatography (SEC) analysis 
Number-average and weight-average molar mass and molar mass distribution (Mw/Mn) were 
determined by SEC conducted in chloroform at 35 °C with a flow rate of 1 mL min-1 using an 
isocratic pump (VE 1122, Viscotek), a PLgel 3 µm MIXED-E (Polymer Laboratories) ultra-high 
efficiency column (300 mm × 7.5 mm) and a Shodex SE 61 differential refractive index detector. 
The injection volume was 100 µL of the sample in chloroform (0.3% w/v). Polystyrene standards 
(Polymer Laboratories) with narrow molar mass distributions were used to generate a calibration 
curve. 
2.5.2. Nuclear magnetic resonance (NMR) analysis: 
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1H NMR spectra of the homo- and copolyesters were recorded using a Bruker-Avance 600 
MHz multinuclear magnetic resonance spectrometer. The analyses were run in CDCl3 using 
tetramethylsilane (TMS) as an internal standard. 
2.5.3. Fourier transform infrared spectroscopy (FTIR) analysis: 
FTIR spectra were recorded using a FTS 40A Bio-Rad spectrometer at room temperature. 
2.5.4. Electrospray mass spectrometry (ESI-MSn) analysis: 
 Electrospray mass spectrometry analysis was performed using a Finnigan LCQ ion trap mass 
spectrometer (Finnigan, San Jose, CA, USA). The obtained bioactive (co)oligoesters were 
dissolved in methanol (99.8%, pure p.a.-basic, POCH SA). The solutions were introduced into 
the ESI source by continuous infusion at a rate of 10 µL min-1 using an instrument syringe pump. 
The LCQ ESI source was operated at 4.5 kV and the capillary was heated to 200 °C. Nitrogen 
was used as the nebulizing gas. For the ESI-MS/MS experiments, monoisotopic ions of interest 
were isolated in the ion trap and collisionally activated using the helium damping gas present in 
the mass analyzer as a collision gas. The RF amplitude, which had a substantial voltage range, 
was set such that the peak height of the molecular ion decreased by at least 50%. The analyses 
were performed in positive-ion mode. 
3. Results and discussion  
In recent years, much attention has been focused on the synthesis of β-lactones by catalytic 
carbonylation of epoxides 13-15. This is a relatively simple synthetic method, thus the obtained 
monomers may be used on a large scale for the synthesis of new biodegradable homo- and 
copolymers with specific characteristics, e.g. for prospective applications of controlled release 
systems of biologically active substances 30. The monomer, 4-methoxy-
benzoyloxymethylpropiolactone (p-AA-CH2-PL), which was used in this study was prepared by 
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carbonylation of a suitable glycidyl ester (Scheme 1a). The resulting new β-substituted β-lactone 
containing covalently attached p-anisic acid was used for the synthesis of biologically active 
(homo)- and (co)oligoesters for prospective applications in cosmetology in controlled release 
systems. Scheme 1b describes the anionic ring-opening oligomerization of p-AA-CH2-PL 
initiated by sodium p-anisate which led to the bioactive (homo)oligoester: oligo(3-hydroxy-3-(4-
methoxybenzoyloxymethyl)propionate), (p-AA-CH2-HP)n (Sample 1, Table 1). Whereas the 
bioactive (co)oligoester: oligo[(3-hydroxy-3-(4-methoxybenzoyloxymethyl)propionate)-co-(3-
hydroxybutyrate)] (p-AA-CH2-HP)m/HBn (Sample 2, Table 1) was synthesized via anionic ring-
opening (co)oligomerization of p-AA-CH2-PL with β-butyrolactone (β-BL) initiated by sodium 
p-anisate (Scheme 1c).  
Scheme 1 
The obtained bioactive (homo)- and (co)oligoesters were preliminarily characterized by SEC, 
1H NMR techniques and ESI-MSn. The results of this characterization of the obtained products 
by SEC are summarized in Table 1.  
Table 1  (Homo)- and (co)oligoester characteristics by SEC. 
Sample 
Composition [mol %]a 
(p-AA-CH2-HP)/HB 
Mnb 
[g/mol] 
Mw/Mnc 
1 100/0 700 1.15 
2 50/50 900 1.23 
a) Molar composition of (co)oligoesters estimated from 1H NMR. 
b) Number-average molar mass and c) molar mass distribution estimated by SEC. 
 The chemical structures of the bioactive (homo)- and (co)oligoesters obtained in this study 
were determined by 1H NMR spectroscopy. The 1H NMR spectrum of (p-AA-CH2-HP)m/HBn is 
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presented in Figure 1. The 1H NMR spectrum reveals signals ascribed to the protons of the 
methyl, methylene and methine groups of 3-hydroxybutyrate and 3-hydroxy-3-(4-
methoxybenzoyloxymethyl)propionate repeating units (corresponding signals: 3, 3’, 1 and 1’ as 
well as 2 and 2’). Additionally, overlapping signals corresponding to the protons of the terminal 
group (derived from the incorporated initiator) and p-anisic acid embedded as side groups along 
the p-AA-CH2-HP chain (signals 4-6’, Figure 1) were detected in the spectrum.  
Figure 1 
3.1. Molecular structural studies of the (homo)oligoester containing bioactive p-anisic acid 
moieties 
 Electrospray ion trap tandem mass spectrometry (ESI-MSn) was applied to obtain detailed 
information about the structure of the resulting (p-AA-CH2-HP)n oligoester at the molecular 
level.  
The ESI mass spectrum of (p-AA-CH2-HP)n oligomers obtained here is depicted in 
Figure 2. One main set of ions with a peak-to-peak mass increment of 236 Da was observed in 
the mass spectrum. The structures of the end groups and repeating units can be inferred based on 
the mass assignment of singly charged ions observed in the mass spectrum. The series of ions 
labeled as (p-AA-CH2-HP)1 – (p-AA-CH2-HP)7 correspond to the sodium cationized 3-
hydroxy-3-(4-methoxybenzoyloxymethyl)propionate oligomers terminated by p-
methoxybenzoyl (p-anisate, derived from the initiator) and carboxyl end groups. 
Figure 2 
Tandem mass spectrometry (ESI-MS/MS) was used for further structural elucidation of the 
oligomers’ structure. In this technique, the molecular ion of interest is separated from the other 
ions formed during the electrospray ionisation process and is induced to dissociate into 
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fragments. These can be used for structural characterization (including end-group analysis) of the 
individual polymer chains. To verify the structure of individual ions belonging to the main series, 
ESI-MS/MS fragmentation experiments were performed for ions selected from this series.   
Previously published studies on the fragmentation of individual precursor ions of polyesters 
(derivatives of β-hydroxy acids) revealed that β-hydrogen rearrangement was the main 
mechanism inducing fragmentation of such polyesters via ester bond cleavage 26, 32-34. 
Figure 3 shows the ESI-MS/MS spectrum of the ion at m/z 883 corresponding to the sodium 
adduct of the oligoester containing three 3-hydroxy-3-(4-methoxybenzoyloxymethyl)propionate  
repeating units terminated by p-anisate and carboxyl end groups. The fragmentation pathway of 
the ion at m/z 883, which occurs as a result of random breakage of ester bonds along the 
oligomer backbone and of ester bonds between the backbone and the bioactive pendant groups, 
is shown in Figure 3. The product ion at m/z 731 corresponds to the oligomer formed by the loss 
of p-anisic acid (152 Da) derivative from the oligomer terminal group or from the bioactive 
pendant group of the p-AA-CH2-HP chain; whereas the product ion at m/z 647 corresponds to the 
oligomer formed by the loss of 4-methoxybenzoyloxycrotonic acid (236 Da). A comparison of 
the fragmentation spectra and the theoretical path of the ion fragmentation showed that all 
theoretically predicted structures of the product ions are shown at the spectrum, which confirms 
the structure of the obtained bioactive oligoester (Figure 3). 
Figure 3 
3.2. ESI-MS reveals the random structure of (p-AA-CH2-HP)m/HBn (co)oligoesters 
The ESI-mass spectrum (positive ion-mode) of oligomers obtained by (co)oligomerization of 
β-BL with p-AA-CH2-PL initiated by sodium p-anisate (together with spectral expansion in the 
range m/z 650–1050) are depicted in Figure 4. Three series of singly charged ions (labeled as A, 
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B and C) that correspond to the three types of oligomers are present in the mass spectrum of the 
sample in Figure 4. Two main sets of ions, which appear in the mass spectrum at m/z =151+(n × 
86)+(m × 236)+1+23 (Figure 4) with a peak-to-peak mass increment of 236 Da (labeled as 
Series A and B), were observed in the mass spectrum. The signals belonging to Series A and B 
correspond to sodium cationized [ (p-AA-CH2-HP)m/HBn + Na]+ (co)oligoester chains 
terminated by p-anisic acid and carboxylic end groups and containing one (Series A) or two 
(Series B) (p-AA-CH2-HP) comonomer units that can be arranged with different combinations 
along the oligomer backbone. The third and less abundant series of ions (with a lower relative 
intensity) labeled Series C (see Figure 4) was observed in the mass spectra at m/z =151+(n x 
86)+1+23. These series can be assigned to sodium cationized oligo(3-hydroxybutyrate) 
terminated by p-anisate and carboxyl end groups. Thus the mass spectrometry analysis indicated 
that the (co)oligoester contained one, two or three bioactive p-anisic moieties distributed along 
the oligomer chains was synthesized (Figure 4). The general structures of the ions present in the 
ESI-MS spectra (Figure 4) are depicted in Table 2.  
The presence of these oligomer chains can be expected at each degree of polymerization, and 
their amount depends on the comonomer ratio, polymerization mechanism, degree of  
copolymerization (e.g. the number of comonomeric units in a macromolecule) as well as on the 
comonomer composition distribution. 
Figure 4 
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 Table 2 Structural assignments of ions appearing in the expanded region (m/z 660-1020) of the 
ESI-MS spectrum of oligomers obtained by (co)oligomerization of β-BL with p-AA-CH2-PL 
initiated by sodium p-anisate. 
Series Chemical Structure 
Composition 
m/z  
(p-AA-CH2 -HP)/HB  
                            
                          
                               
 
 
A 
B 
C 
 
 
(p-AA-CH2-HP)1/HB3           669 
(p-AA-CH2-HP)1/HB4            755 
(p-AA-CH2-HP)1/HB5             841 
(p-AA-CH2-HP)1/HB6            927 
(p-AA-CH2-HP)1/HB7          1013 
 
 
(p-AA-CH2-HP)2/HB1             733 
(p-AA-CH2-HP)2/HB2             819 
(p-AA-CH2-HP)2/HB3             905 
(p-AA-CH2-HP)2/HB4             991                                         
 
 
 
                HB6                                691          
                HB7                                777        
                HB8                                863   
                HB9                                949 
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3.3. Structural characterization of random (p-AA-CH2-HP)m/HBn (co)oligoesters with tandem 
ESI-MS/MS  
More detailed insight into the structure of individual (co)oligoester chains may be obtained by 
using tandem ESI-MS/MS spectrometry. This technique has been applied for structural studies 
and investigation of fragmentation product patterns of individual molecular ions while allowing 
differentiation between individual molecular chains of random and diblock copolyesters 33. 
Figure 5 presents the ESI-MS/MS spectrum (in positive-ion mode) of the precursor ion at m/z  
841,  which  corresponds  to  the  sodium  adduct  of oligomers terminated by carboxyl and p-
anisate (derived from the initiator used) end groups and containing five 3-hydroxybutyrate 
repeating units and one p-AA-CH2-HP unit in the (co)oligoester chain. Fragmentation of this 
precursor ion at m/z 841 (belonging to Series A, Figure 4) takes place as a result of random 
breakage of ester bonds along the oligomer chain and ester bonds between the chain and the 
bioactive pendant group (see the fragmentation pathway in Figure 5 and Scheme 2). Thus the 
product ion at m/z 689 corresponds to the oligomer formed by the loss of p-anisic acid (152 Da), 
which can be derived from the terminal group and/or from the bioactive pendant group of the p-
AA-CH2-HP comonomer unit. While the product ion at m/z 755 corresponds to the oligomer 
formed by the loss of the last 3-hydroxybutyrate unit in the oligoester chains in the form of 
crotonic acid (86 Da), the formation of the product ion at m/z 605 is associated with the loss of 4-
methoxybenzoyloxycrotonic acid (236 Da, see Scheme 2) if the last comonomer unit in the 
oligoester chain is p-AA-CH2-HP. All theoretically predicted product ions are present in the ESI-
MS/MS spectrum in Figure 5, which is in good agreement with the theoretical fragmentation 
pathways we proposed in Scheme 2. Moreover, such a fragmentation pathway indicates that the 
p-AA-CH2-HP comonomer unit is randomly distributed along the oligomer chain.  
15 
 
Figure 6 shows the ESI-MS/MS product ions’ spectrum of the precursor ion at m/z 819 
corresponding to the sodium adduct of [p-AA-(p-AA-CH2-HP)2/HB2 + Na+] (co)oligoester 
chains terminated by p-anisate and carboxyl end groups, containing two HB and two p-AA-CH2-
HP repeating units in the (co)oligoester chain. In this case, random breakage of ester bonds along 
the oligomer chain and ester bonds between the chain and the bioactive pendant group led to the 
formation of two series of product ions at m/z 733, 667, 647, 583, 581, 497, 495, 431, 411.  
Thus the product ion at m/z 667 corresponds to the oligomer formed by the loss of the p-anisic 
acid molecule (152 Da), a derivative from the oligomer end group or from the bioactive 
pendant group of the p-AA-CH2-HP comonomer unit. While the product ion at m/z 733 
corresponds to the oligomer formed by the loss of HB units in the form of crotonic acid if the 
HB unit is the last comonomer unit in the oligoester chain (86 Da; see Figure 6 and Scheme 3). 
The product ion at m/z 583 corresponds to the oligomer formed by the loss of the last, in the 
oligoester chain, p-AA-CH2-HP comonomer unit in the form of 4-methoxybenzoyloxycrotonic 
acid (236 Da, see Scheme 3). Such a fragmentation pathway indicates that the two p-AA-CH2-
HP comonomer units are randomly distributed along the oligomer chain 33. 
ESI-MS/MS experiments were also performed for ions derived from Series C (assigned as HBn 
in the spectral expansion in Figure 4). The selected ions correspond to the sodium adducts of p-
AA-oligo(3-hydroxybutyrate) (p-AA-OHB) chains terminated by p-anisate and carboxylic end 
groups. Fragmentation of these ions proceeds via a similar fragmentation pathway and was 
previously reported in ref. 18. 
Figure 5 
Scheme 2 
Figure 6 
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Scheme 3 
 
4. Conclusions 
The results of the present study revealed that anionic oligomerization of β-substituted β-
lactones containing covalently bonded p-anisic acid enabled the formation of bioactive 
(homo)oligoesters having from 1 to 8 molecules of p-anisic acid and (co)oligoesters containing 
from 2 to 3 molecules of p-anisic acid bound to the polymer backbone as a bioactive terminal 
and pendant groups through hydrolyzable ester linkages.  
An analytical method for a detailed structural characterization at the molecular level of 
bioactive (co)oligoesters has been developed. The molecular structures of the obtained (homo)- 
and (co)oligoesters were determined with the use of ESI-mass spectrometry supported by 1H 
NMR analyses. Structures of the end groups and copolymer composition were verified by ESI-
MS/MS. It was shown that fragmentation of selected ions of bioactive (co)oligoesters proceeded 
via random breakage of ester bonds along the oligomer chain as well as of ester bonds of the 
bioactive pendant group. Additionally, the ESI-MS/MS fragmentation experiments conducted for 
selected sodium adducts of the obtained (co)oligoesters confirmed that the bioactive moieties 
were covalently bonded to oligo(3-hydroxybutyrate) chains as terminal and pendant groups. 
Moreover, the fragmentation pathway of selected oligomers indicated that the p-AA-CH2-HP 
comonomer units were randomly distributed along the (co)oligoester chain. Thus the obtained 
results demonstrate the utility of this technique for the analysis of individual molecules of the 
bioactive (homo)- and (co)oligoesters studied here. 
Novel delivery systems obtained via the elaborated synthetic strategy contain a larger 
loading of biologically active substances per polymer macromolecule than the respective 
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cosmetic delivery system that we have already reported 16-18. The object of further work will be 
to carry out preliminary studies proving the usefulness of the developed (co)oligoesters as new 
controlled release systems for applications in cosmetology.  
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Figure captions: 
Figure 1. 1H NMR spectrum (in CDCl3) of the (p-AA-CH2-HP)m/HBn oligomer obtained via co-
oligomerization of β-BL with p-AA-CH2-PL initiated by sodium p-anisate. 
Figure 2. ESI-mass spectrum (positive-ion mode) of the (p-AA-CH2-HP)n (homo)oligoester 
obtained via anionic ring-opening oligomerization (p-AA-CH2-PL) initiated by sodium p-anisate. 
Figure 3. ESI-MS/MS spectrum of the sodium adduct of oligomers containing three 3-hydroxy-
3-(4-methoxybenzoyloxymethyl)propionate repeating units and the theoretical fragmentation 
pathway. 
Figures 4. ESI-mass spectra (positive ion-mode) of oligomers obtained by (co)oligomerization 
of β-BL with p-AA-CH2-PL initiated by sodium p-anisate and spectral expansion in the mass 
range m/z 660-1020. 
Figure 5.  ESI-MS/MS spectrum (in positive-ion mode) of a selected sodium adduct of [p-AA-
(p-AA-CH2-HP)1/HB5 + Na]+ (co)oligoester at m/z 841 terminated by p-anisic acid and 
carboxylic end groups and containing one p-AA-CH2-HP comonomer unit. 
Figure 6. ESI-MS/MS spectrum (in positive-ion mode) of a selected sodium adduct of [p-AA-(p-
AA-CH2-HP)2/HB2 + Na]+ (co)oligoester at m/z 819 terminated by p-anisic acid and carboxylic 
end groups and containing two p-AA-CH2-HP comonomer units. 
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Scheme 1. Synthesis of (a) 4-methoxybenzoyloxymethylpropiolactone, (b) oligo(3-hydroxy-3-
(4-methoxybenzoyloxymethyl)propionate), and (c) oligo[(3-hydroxy-3-(4-methoxybenzoyloxy- 
methyl)propionate)-co-(3-hydroxybutyrate)]. 
Scheme 2. Theoretical fragmentation pathway of the sodium adduct of [(p-AA-CH2-HP)1/HB5 + 
Na]+ (co)oligoester at m/z 841 terminated by p-anisic acid and carboxyl end groups containing 
one p-AA-CH2-HP comonomer unit. 
Scheme 3. Theoretical fragmentation pathway of the sodium adduct of [p-AA-(p-AA-CH2-
HP)2/HB2 + Na]+  (co)oligoester at m/z 819 terminated by p-anisic acid and carboxyl end groups 
containing two p-AA-CH2-HP comonomer units. 
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